Skip to content

Leucine-rich repeat and transmembrane domain-containing protein 2 (LRTM2)

Homo sapiens — UniProt Q8N967

Gene: LRTM2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Leucine-rich repeat and transmembrane domain-containing protein 2 (LRTM2) is a protein from Homo sapiens identified by UniProt accession Q8N967, 370 residues long. MolForge cross-references it against 0 known binders and 17 disease associations.

  • UniProt accession: Q8N967; gene symbol LRTM2.
  • Organism: Homo sapiens.
  • Length: 370 amino acids.
  • Top disease associations (Open Targets): mathematical ability, self reported educational attainment and central nervous system cancer.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameLeucine-rich repeat and transmembrane domain-containing protein 2
UniProt accessionQ8N967
GeneLRTM2
OrganismHomo sapiens
Length370 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (17)

Diseases linked to this target (Open Targets).

  • mathematical ability · score 0.18
  • self reported educational attainment · score 0.17
  • central nervous system cancer · score 0.04
  • lymphocyte count · score 0.03
  • glioblastoma multiforme · score 0.03
  • breast carcinoma · score 0.03
  • Agents acting on the renin-angiotensin system use measurement · score 0.02
  • septic shock · score 0.01
  • neoplasm · score 0.01
  • autism · score 0.01

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8N967-F1alphafoldPREDICTED79.88—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8N967.

Amino-acid sequence (370 residues)

MLAPGSSPGQ RGRLALQWRQ VSWITCWIAL YAVEALPTCP FSCKCDSRSL EVDCSGLGLT TVPPDVPAAT RTLLLLNNKL SALPSWAFAN LSSLQRLDLS NNFLDRLPRS IFGDLTNLTE LQLRNNSIRT LDRDLLRHSP LLRHLDLSIN GLAQLPPGLF DGLLALRSLS LRSNRLQNLD RLTFEPLANL QLLQVGDNPW ECDCNLREFK HWMEWFSYRG GRLDQLACTL PKELRGKDMR MVPMEMFNYC SQLEDENSSA GLDIPGPPCT KASPEPAKPK PGAEPEPEPS TACPQKQRHR PASVRRAMGT VIIAGVVCGV VCIMMVVAAA YGCIYASLMA KYHRELKKRQ PLMGDPEGEH EDQKQISSVA

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LRTM2?

The strongest Open Targets associations for LRTM2 are mathematical ability, self reported educational attainment, central nervous system cancer, lymphocyte count and glioblastoma multiforme.

How long is the LRTM2 protein?

The Homo sapiens LRTM2 protein (UniProt Q8N967) is 370 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Leucine-rich repeat and transmembrane domain-containing protein 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8N967
GeneLRTM2
OrganismHomo sapiens
Length370
Binders0
Diseases17
View on UniProt